Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trialAnnane D, Pittock SJ, Kulkarni HS, Pickering BW, Khoshnevis MR, Siegel ...
Lung epithelial cell-derived C3 protects against pneumonia-induced lung injurySahu SK, Ozanturk AN, Kulkarni DH, Ma L, Barve RA, Dannull ...
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infectionMa L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter ...
Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19Scozzi D, Cano M, Ma L, Zhou D, Zhu JH, O’Halloran ...
